The EU has said that the UK will not be able to take part in any EU agencies, including the European Medicines Agency, once it leaves the European Union. Nonetheless, there will still be scope for some flexibility on the part of the EU, and informal collaboration on specific regulatory activities, as already takes place among international regulators, is a likely way forward for the future relationship, according to experts who spoke to the Pink Sheet.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?